Innocrin Pharmaceuticals Overview

  • Founded
  • 2014

Founded
  • Status
  • Out of Business

  • Employees
  • 10

Employees
  • Latest Deal Type
  • Out of Business

Innocrin Pharmaceuticals General Information

Description

Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating castration-resistant prostate cancer and are used in other hormonally-driven conditions such as endometriosis or congenital adrenal hyperplasia, thereby enabling hospitals to treat even non-oncologic syndromes caused due to excessive androgen production.

Contact Information

Formerly Known As
Hephestics, Viamet Pharmaceuticals
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Medical Supplies
Therapeutic Devices
Drug Delivery
Primary Office
  • 4220 Appex Highway 55
  • Suite 330
  • Durham, NC 27713
  • United States
+1 (919) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innocrin Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Oct-2019 000.00 Completed Out of Business
3. Later Stage VC 13-Jul-2017 000 000.00 Completed Generating Revenue
2. Later Stage VC 20-Apr-2015 $28.1M $28.1M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Innocrin Pharmaceuticals’s complete valuation and funding history, request access »

Innocrin Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating cas
Drug Discovery
Durham, NC
10 As of 2016
000.00
00000000 00 000.00

000000

mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in re
0000 00000000
Deerfield, IL
00 As of 0000
00000
0000000 0000 00000

000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000 000000000
Middleton, WI
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Innocrin Pharmaceuticals Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aerami Therapeutics Private Equity-Backed Deerfield, IL 00 00000 0000000 0000 00000
00000000 Venture Capital-Backed Middleton, WI 00 000.00 0000000000 0 000.00
00000000 00000000 Corporate Backed or Acquired Cary, NC 00 000000&0
0000000000 Venture Capital-Backed Pittsburgh, PA 00 0000 00000000000 0000
0000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
You’re viewing 5 of 15 competitors. Get the full list »

Innocrin Pharmaceuticals Patents

Innocrin Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2751117-A4 Metalloenzyme inhibitor compounds Inactive 30-Aug-2011 0000000000
EP-2751117-A2 Metalloenzyme inhibitor compounds Inactive 30-Aug-2011 0000000000
US-9150527-B2 Metalloenzyme inhibitor compounds Inactive 30-Aug-2011 0000000000
US-20140303157-A1 Metalloenzyme inhibitor compounds Active 30-Aug-2011 0000000000
AU-2012300275-A1 Metalloenzyme inhibitor compounds Inactive 30-Aug-2011 C07D277/24
To view Innocrin Pharmaceuticals’s complete patent history, request access »

Innocrin Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial